Actavis, Allergan announce SEC declaration, shareholder meetings on pending acquisition

Actavis and Allergan announced that the U.S. Securities and Exchange Commission has declared Actavis’ registration statement on Form S-4 with regard to Actavis’ pending acquisition of Allergan to be effective.The two companies also announced in a press release that they have scheduled special shareholder meetings on March 10 in connection with the pending acquisition.